In order to achieve the radio-therapeutic strategic goals and accommodate the needs of a variety of therapies for radionuclide medical areas worldwide, Full-Life is building world-leading manufacturing sites to produce radiopharmaceutical drug products that can meet key market GMP standard.

Full-Life works with top supply-chain partners to ensure our products can reach the patients worldwide in a timely matter, satisfying our growing clinical need of the expanding innovative pipeline developed in house.